COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 1950: Articles 19491-19500  | Next

Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
Banach, B. B., Cerutti, G., Fahad, A. S., Shen, C.-H., Oliveira de Souza, M., Katsamba, P. S., Tsybovsky, Y., Wang, P., Nair, M. S., Huang, Y., Francino Urdaniz, I. M., Steiner, P. J., Gutierrez-Gonzalez, M., Liu, L., Lopez Acevedo, S. N., Nazzari, A., Wolfe, J. R., Luo, Y., Olia, A. S., Teng, I.-T., Yu, J., Zhou, T., Reddem, E. R., Bimela, J., Pan, X., Madan, B., Laflin, A. D., Nimrania, R., Yuen, K.-T., Whitehead, T. A., Ho, D. D., Kwong, P. D., Shapiro, L., DeKosky, B. J.
10.1101/2020.12.31.424987 — Posted: 2021-01-03
Direct detection of SARS-CoV-2 RNA using high-contrast pH-sensitive dyes
Brown, T. A., Schaefer, K. S., Tsang, A., Yi, H. A., Grimm, J. B., Lemire, A. L., Jradi, F. M., Kim, C., McGowan, K., Ritola, K., Armstrong, D. T., Mostafa, H. H., Korff, W., Vale, R. D., Lavis, L. D.
10.1101/2020.12.26.20248878 — Posted: 2021-01-03
Non-medical COVID-19-related personal impact in medical ecological perspective: A global multileveled, mixed method study
Dye, T. D. V., Levandowski, B., Siddiqi, S., Perez Ramos, J. G., Li, D., Sharma, S., Muir, E., Wiltse, S., Royzer, R., Panko, T., Hall, W., Barbosu, M., Irvine, C., Pressman, E.
10.1101/2020.12.26.20248865 — Posted: 2021-01-02
Covid-19, Lockdowns and Motor Vehicle Collisions: Empirical Evidence from Greece
Vandoros, S.
10.1101/2020.12.26.20248883 — Posted: 2021-01-02
Probability that an infection like Covid-19 stops without reaching herd immunity, calculated with a stochastic agent-based model.
Eissler, M. K. R.
10.1101/2020.12.27.20248905 — Posted: 2021-01-02
The evaluation of a newly developed antigen test (QuickNavi™-COVID19 Ag) for SARS-CoV-2: A prospective observational study in Japan
Takeuchi, Y., Akashi, Y., Kato, D., Kuwahara, M., Muramatsu, S., Ueda, A., Notake, S., Nakamura, K., Ishikawa, H., Suzuki, H.
10.1101/2020.12.27.20248876 — Posted: 2021-01-02
The Ugandan Severe Acute Respiratory Syndrome -Coronavirus 2 (SARS-CoV-2) Model: A Data Driven Approach to Estimate Risk
Nannyonga, B. K., Bosa, H. K., Wodermariam, Y. T., Kaleebu, P., Ssenkusu, J., Lutalo, T., Kirungi, W., Makumbi, F. E., Ssembatya, V. A., Mwebesa, H. G., Atwine, D., Aceng, J. R., Wanyenze, R. K.
10.1101/2020.12.28.20248922 — Posted: 2021-01-02
Simulating the impacts of interregional mobility restriction on the spatial spread of COVID-19 in Japan
Kondo, K.
10.1101/2020.12.28.20248926 — Posted: 2021-01-02
COVID-19 severity impacts on long-term neurological manifestation after hospitalisation
Pilotto, A., cristillo, v., cotti Piccinelli, s., Zoppi, N., Bonzi, G., Sattin, D., Schiavolin, S., Raggi, A., Canale, A., Gipponi, S., Libri, I., frigerio, m., Bezzi, M., leonardi, M., padovani, a.
10.1101/2020.12.27.20248903 — Posted: 2021-01-02 Discussion: Onsite
Number of tests required to flatten the curve of coronavirus disease-2019
Hwang, S., Kim, J.-H., Choe, Y. J., Oh, D.-h.
10.1101/2020.12.26.20248818 — Posted: 2021-01-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).